Suven Pharmaceuticals Ltd up by 10.55 % - Traders Corners | Espresso

EspressoLogy

Espresso Shot of the Day - Suven Pharmaceuticals Ltd up by 10.55 percent

March 23, 2022
Espresso Shot of the Day - Suven Pharmaceuticals Ltd up by 10.55 percent

SUVEN PHARMACEUTICALS LTD 589.10 (+10.55%) BSE – INE03QK01018 | 23RDMARCH 2022


Suven Pharmaceuticals Limited, a company incorporated in November 2018, has become a Wholly Owned Subsidiary of Suven Life Sciences Limited, effective February 2019. Suven Life Sciences Limited, the demerged entity, will continue innovative research focused on Central Nervous System (CNS) disorders to meet huge unmet global medical needs. Suven Pharmaceuticals Limited, the resultant entity, will continue the CRAMS business operations. The Scheme of Arrangement has since been approved by the Hon’ble National Company Law Tribunal (NCT), Hyderabad bench vide its order on 6th January 2020.


Recent Drivers

  • On Feb 09, 2022, the company reported Net Sales at Rs.391.59 crores in December 2021 up 42.43% from Rs.274.93 crores in December 2020.
  • On Feb 09, 2022, the company reported a Quarterly Net Profit at Rs.160.07 crores in December 2021 up 40.87% from Rs.113.63 crores in December 2020.
  • On Feb 08, 2022, the company declared a dividend of a total Rs.3.00 per equity share.
  • On Jan 20, 2022, the company reported that Dr. Chandrasekhar Srivari resigned from the position of the Non-executive Independent Director of the Company.
  • On Dec 14, 2022, the company divested its entire 25% stake in U.S. firm Rising Pharma Holdings Inc to Raisin Aggregator, L.P. USA, an arm of global alternative investment firm H.I.G. Capital.
(Sources: The Hindu,Moneycontrol, BSE)


Technical Force*

  • S&P BSE 500 month till date gain up by 2.68%
  • Traded on 52 Week high value 597.50
  • 3 months avg. NSE volume: 349,755
  • Quantity traded: 76,63 | Deliverable Quantity: 23,702(30.93%)
  • Stock price has jumped by more than 30% from a one-year low level: 445.50 (Mar 25, 2021)
  • Daily RSI (14) is nearby Overbought territory today
  • 52-week-high: 597.50 | 52-week-low: 455.50


Key Pivot  (Yearly)

R4

R3

R2

R1

PP /FIB PP

S1

S2

S3

S4

Pivot Point

-

739.83

664.82

578.98

503.97

418.13

343.12

257.28

    -

Fibonacci Pivot

664.82

603.37

565.41

540.96

503.97

466.97

442.52

404.56

343.12


Today’s Close

589.10

SMA

BSE

10 DAY

525.72

20 DAY

518.45

50 DAY

528.92

200 DAY

514.85


Some Key Ratios (Source: BSE)

Market Cap: 14,996.42Crores

PE: 37.67

OPM%: 49.87

ROE%: 32.21

Promoters holding%: 60.00

Prev. Close: 532.90


*Chart and Technical Force data from the Binge desktop app
The scope and usability of this information/data is time-sensitive and market-based, and as such the same may become outdated for the investment decisions of clients, for which Sharekhan Comtrade bears no responsibility. References to securities do not constitute a recommendation to buy, sell or hold such securities. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document and should consult his own advisors to determine the merits and risks of such an investment. Sharekhan Comrade Private Limited is under no obligation to update the information in this document from time-to-time.


Chandresh Khona
by Chandresh Khona

Product Offerings Head

A teacher, writer, travel buff and now Espresso's Product Offerings Head. Ten years here has allowed me to lead the digital team at Sharekhan. My true passion lies in stock market charts.